Valuation : Thor Medical

Market Cap 2B 215M 185M 174M 159M 297M 20.28B 299M 2.07B 802M 10.37B 806M 788M 34.06B P/E 2026 *
-27.8x
P/E 2027 * -46.3x
Enterprise Value 2.2B 236M 203M 192M 175M 326M 22.28B 329M 2.27B 881M 11.39B 886M 866M 37.41B EV / Sales 2026 *
110x
EV / Sales 2027 * 15.2x
Free-Float
59.77%
Yield 2026 *
-
Yield 2027 * -
1 week-20.49%
Current month-2.29%
1 month-4.15%
3 months+27.00%
6 months+37.55%
Current year+5.71%
1 week 5.37
Extreme 5.37
6.68
1 month 5.14
Extreme 5.14
7.12
Current year 3.88
Extreme 3.88
7.12
1 year 3.18
Extreme 3.175
7.12
3 years 0.85
Extreme 0.85
7.12
5 years 0.85
Extreme 0.85
7.12
10 years 0.85
Extreme 0.85
7.12
Manager TitleAgeSince
Chief Executive Officer 41 2024-07-31
Director of Finance/CFO 37 2023-06-30
Chief Tech/Sci/R&D Officer - 2023-05-31
Director TitleAgeSince
Director/Board Member 67 2023-06-27
Chairman 59 -
Director/Board Member - 2025-04-23
Date Insider Type Main position Quantity % Market Cap. Importance
6/26/25
Scatec Innovation AS
OthersCompany 31,577,399 10.0434%
6/18/25
Scatec Innovation AS
BuyCompany 3,000,000 0.9542%
5/2/25 Exercice

Director

164,641 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-20.49%+68.18%+337.01% 219M
+1.03%-2.05%+39.28%+94.60% 68.21B
+1.62%+0.33%+48.61%+88.33% 64.25B
+4.21%+1.80%-12.85%+459.32% 26.54B
+3.27%+0.69%+39.01%+13.13% 25.9B
+1.83%-7.77%+3.17%-14.74% 25.61B
+1.30%+0.74%+31.66%-17.99% 19.88B
-0.38%-17.67%+214.37%+373.18% 17.13B
+0.53%-5.51%-3.49%+538.25% 14.93B
+2.88%+4.33%+57.42%+157.39% 14.1B
Average +1.63%-5.28%+48.54%+202.85% 27.68B
Weighted average by Cap. +1.75%-3.14%+42.01%+146.85%

Financials

2026 *2027 *
Net sales 20M 2.15M 1.85M 1.75M 1.59M 2.97M 203M 3M 20.67M 8.02M 104M 8.07M 7.89M 341M 145M 15.58M 13.44M 12.66M 11.53M 21.56M 1.47B 21.72M 150M 58.17M 752M 58.5M 57.22M 2.47B
Net income -70M -7.52M -6.49M -6.11M -5.57M -10.41M -710M -10.49M -72.36M -28.08M -363M -28.24M -27.62M -1.19B -44M -4.73M -4.08M -3.84M -3.5M -6.54M -447M -6.59M -45.48M -17.65M -228M -17.75M -17.36M -750M
Net Debt 197M 21.16M 18.26M 17.2M 15.67M 29.29M 2B 29.51M 204M 79.03M 1.02B 79.47M 77.74M 3.36B 201M 21.59M 18.63M 17.55M 15.99M 29.89M 2.04B 30.11M 208M 80.63M 1.04B 81.09M 79.32M 3.43B
Logo Thor Medical
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells
Employees
-
Date Price Change Volume
26-09-02 NOK 5.550 -2.29% 5,053,201
26-09-01 NOK 5.680 0.00% 14,481,614
26-08-31 NOK 5.680 -5.49% 5,651,489
26-08-28 NOK 6.010 -11.49% 14,572,635
26-08-27 NOK 6.790 -2.72% 3,786,024
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
5.550NOK
Average target price
4.200NOK
Spread / Average Target
-24.32%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NANOV Stock